Environmental estrogens: Effects on cholesterol lowering and bone in the ovariectomized rat

Journal of Steroid Biochemistry and Molecular Biology

Volumn 59, Issue 2, 1996, Pages 155-161

  Dodge, Jeffrey A ^a   Glasebrook, Andrew L ^a   Magee, David E ^a   Phillips, David L ^a   Sato, Masahiko ^a   Short, Lorri L ^a   Bryant, Henry U ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; COUMESTROL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; GENISTEIN; METHOXYCHLOR; ZERANOL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE METABOLISM; BREAST CANCER; CELL LINE; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; ORAL DRUG ADMINISTRATION; OVARIECTOMY; RAT; UTERUS WEIGHT;

ADENOCARCINOMA; ANIMALS; ANTICHOLESTEREMIC AGENTS; BINDING, COMPETITIVE; BONE DENSITY; BREAST NEOPLASMS; CELL LINE; CHOLESTEROL; COUMESTROL; ENVIRONMENTAL POLLUTANTS; ESTRADIOL; ESTROGENS, NON-STEROIDAL; FEMALE; GENISTEIN; HUMANS; ISOFLAVONES; KINETICS; METHOXYCHLOR; OVARIECTOMY; PHENOLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; UTERUS; ZERANOL;

EID: 0030267829     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(96)00104-5     Document Type: Article

References (33)

1. 1. Henderson B. E., Ross R. K. and Pike M. C.: Toward the primary prevention of cancer. Science 254 (1991) 1131-1138.
2. 2. Henderson B. E., Ross R. K. and Bernstein I.: Estrogens as the cause of human cancer. Cancer Res. 48 (1988) 246-253.
3. 3. McLachlan J. A.: Estrogens in the Environment. Elsevier, North Holland (1980) and McLachlan J. A.: Estrogen in the Environment II, Influences on Development. Elsevier, New York, (1985).
4. 3. McLachlan J. A.: Estrogens in the Environment. Elsevier, North Holland (1980) and McLachlan J. A.: Estrogen in the Environment II, Influences on Development. Elsevier, New York, (1985).
5. 4. Sharpe R. M. and Skakkebaek N. E.: Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract. Lancet 341 (1993) 1392-1395.
6. 5. Di Raimondo C. V., Roach A. C. and Meador C. K.: Gynecomastia from exposure to vaginal estrogen cream. N. Engl. J. Med. 302 (1980) 1089-1090.
7. 6. Comas A. P.: Precocious sexual development in Puerto Rico. Lancet 329 (1982) 1299-1300.
8. 7. Adlercreutz H.: Diet, breast cancer, and sex hormone metabolism. Ann. NY Acad. Sci. 595 (1990) 281-289.
9. 8. Adlercreutz H., Hamalainen E., Gorbach S. and Goldin B.: Dietary phyto-oestrogens and the menopause in Japan. Lancet 339 (1992) 1233-1234.
10. 9. Wenger N. K., Speroff L. and Packard B.: Cardiovascular health and disease in women. N. Engl. J. Med. 329 (1993) 247-256.
11. 10. Richelson L. S., Wahner H. W. and Melton L. J.: Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N. Engl. J. Med. 311 (1984) 1273-1275.
12. 11. Stone R.: Environmental estrogens stir debate. Science 265 (1994) 308-310.
13. 12. Colborn T. and Clement C.: Chemically-induced Alterations in Sexual Function and Development: The Wildlife/Human Connection. Princeton Scientific, Princeton, NJ (1992).
14. 13. Hileman B.: Environmental estrogens linked to reproductive abnormalities, cancer. Chem. Engng News 72 (1994) 19-23.
15. 14. McLachlan J. A.: Functional toxicology: a new approach to detect biologically active xenobiotics. Environ. Hlth Perspect. Sci. News 144 (10) (1993) 386-387.
16. 15. Tsutsumi N.: Effect of coumestrol on bone metabolism in organ culture. Biol. Pharmacol. Bull. 18 (1995) 1012-1015.
17. 16. Kaup S. M., Right S. C., Ahn S. M., Ford C. E. and Wiesenfeld P. W.: Mineral metabolism and bone mineralization in mature female rats fed flaxseed. J. Bone Min. Res. 8 (S1) (1994) S397.
18. 17. Powell-Jones W., Raeford S. and Lucier G. W.: Binding properties of zearalenone mycotoxins to hepatic estrogen receptors. Molec. Pharmacol. 20 (1981) 35-42.
19. 18. Katzenellenbogen B. S., Katzenellenbogen J. A. and Mordecai D.: Zearalenones: characterization of the estrogenic potencies and receptor interactions of a series of fungal β-resorcylic acid lactones. Endocrinology 105 (1979) 33-40.
20. 19. Bitman J. A. and Cecil H. C.: Estrogenic activity of DDT analogs and polychlorinated biphenyls. J. Agr. Food Chem. 18 (1970) 1108-1112.
21. 20. Nelson J. A., Struck R. F. and James R.: Estrogenic activities of chlorinated hydrocarbons. J. Toxicol. Environ. Hlth 4 (1978) 325-339.
22. 21. White R., Jobling S., Hoare S. A., Sumpter J. P. and Parker M. G.: Environmentally persistant alkylphenolic compounds are estrogenic. Endocrinology 135 (1994) 175-182.
23. 22. Krishnan A. V., Stathis P., Permuth S. F., Tokes L. and Feldman D.: Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 132 (1993) 2279-2286.
24. 23. Wronski T. J., Yen C.-Y., Burton K. W., Mehta R. C., Newman P. S., Soltis E. E. and DeLuca P. P.: Skeletal effects of calcitonin in ovarietomized rats. Endocrinology 129 (1991) 2246-2250.
25. 24. Wronski T. J. and Yen C.-F.: The ovariectomized rat as an animal model for postmenopausal bone loss. Cells Mater. (Suppl 1) (1991) 69-74.
26. 25. Kalu D. N.: The ovariectomized rat model of post-menopausal bone loss. Bone Min. 15 (1991) 175-192.
27. 26. Brown M. S. and Goldstein J. L.: The estradiol-stimulated lipoprotein receptor of rat liver. J. Biol. Chem. 254 (1980) 11360-11366.
28. 27. Walsh B. W., Schiff I., Rosner B., Greenberg L., Ravnikar V. Sacks F. M.: Effects of post-menopausal estrogen replacement therapy on the concentrations and metabolism of plasma lipoproteins. N. Engl. J. Med. 325 (1991) 1196-1204.
29. 28. Black L. J., Sato M., Rowley E. R., Magee D. E., Bekele A., Williams D. C., Cullinan G. G., Bendele R., Kauffman R. F., Bensch W. R., Frolik C. A., Termine J. D. and Bryant H. U.: Raloxifene (LY139481 HCl) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J. Clin. Invest. 93 (1994) 62-69.
30. 29. Washburn S. A., Adams M. R., Clarkson T. B. and Adelman S. J.: A conjugated equine estrogen with differential effects on uterine weight and plasma cholesterol in the rat. Am. J. Obstet. Gynecol 169 (1993) 251-256.
31. 30. Wilson T. M., Henke B. R., Momtahen T. M., Charifson P. S., Batchelor K. W., Lubahn D, B., Moore L. B., Oliver B. B., Sauls H. R., Triantafillou J. A., Wolfe S. G. and Baier P. G.: 3-{4-(1,2-Diphenylbut-1-enyl)phenyl]acrylic acid: a non-steroidal estrogen with functional selectivity for the bone over uterus in rats. J. Med. Chem. 37 (1994) 1550-1552.
32. 31. Robertson D. W., Katzenellenbogen J. A., Long D. J., Rorke E. A. and Katzenellenbogen B. S.: Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifen. J. Steroid Biochem. 16 (1982) 1-13.
33. 32. McDonnell D. P., Dana S. L., Hoener P. A., Lieberman B. A., Imhof M. O. and Stein R. B.: Cellular mechanisms which distinguish between hormone-and antihormone-activated estrogen receptor. Ann. NY Acad. Sci. 761 (1995) 121-137.